$2.11
-0.41-16.27%
Last update: Nov 5, 1:52 PM
Niagen Bioscience Inc
NAGENASDAQ
The average analyst price target for Niagen Bioscience is $14.33, 579.1% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $9 to $23. The latest change came on Oct 30, 2026, when Canaccord Genuity lowered its price target on Niagen Bioscience from $10 to $9 and kept a Buy rating.
Price Target Range — 7 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
